(Q59616701)
Statements
Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study (English)
Miguel A Climent
Hernán Cortés-Funes
Pere Gascón
José I Mayordomo
Miguel Gil
Manuel Benavides
Lluís Cirera
Belén Ojeda
César A Rodríguez
José M Trigo
Josep Vazquez
Pilar Regueiro
Juan F Dorado
José Baselga
Spanish Breast Cancer Cooperative Group SOLTI
1 January 2009